A case of acute disseminated encephalomyelitis presenting hypersomnia with decreased hypocretin level in cerebrospinal fluid

Journal of Child Neurology

Volumn 17, Issue 7, 2002, Pages 537-539

  Kubota, Hiroaki ^a   Kanbayashi, Takashi ^b   Tanabe, Yuzo ^a   Takanashi, Jun Ichi ^a   Kohno, Yoichi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; METHYLPREDNISOLONE; NEUROPEPTIDE RECEPTOR; OREXIN; PREDNISOLONE;

AROUSAL; ARTICLE; BASAL GANGLION; BRAIN STEM INJURY; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; ENCEPHALOMYELITIS; FEMALE; HUMAN; HYPERSOMNIA; HYPOTHALAMUS LESION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; REGULATORY MECHANISM; SCHOOL CHILD; WHITE MATTER;

CARRIER PROTEINS; CHILD; DISORDERS OF EXCESSIVE SOMNOLENCE; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAGNETIC RESONANCE IMAGING; NEUROPEPTIDES; PREDNISOLONE; RADIOIMMUNOASSAY; TREATMENT OUTCOME;

EID: 0036656698     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380201700713     Document Type: Article

References (14)

1. Alvord EC Jr: Disseminated encephalomyelitis: Its variations in form and their relationships to other diseases of the nervous system, in Vinken PJ, Bruyn GW, Klawans HL (eds): Handbook of Clinical Neurology, vol 47, series 3. Amsterdam, Elsevier Science Publishers, 1985;467-502.
2. Hyson JL, Kornberg AJ, Coleman LT, et al: Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001;56:1308-1312.
3. Dale RC, de Sousa C, Chong WK, et al: Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123:2407-2422.
4. Nishino S, Ripley B, Overeem S, et al: Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40.
5. Poirier G, Montplaisir J, Dumont M, et al: Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology 1987;37:693-695.
6. Kanbayashi T, Goto A, Hishikawa Y, et al: Hypersomnia due to acute disseminated encephalomyelitis in a 5-year-old girl. Sleep Med 2000;2: 347-350.
7. von Economo C: Sleep as a problem of localization. J Nerv Ment Dis 1930;71:249-259.
8. Chemelli RM, Willie JT, Sinton CM, et al: Narcolepsy in orexin knock-out mice: Molecular genetics of sleep regulation. Cell 1999;98:437-451.
9. Lin L, Faraco J, Li R, et al: The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365-376.
10. Peyron C, Faraco J, Rogers W, et al: A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-997.
11. Nishino S, Ripley B, Overeem S, et al: Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 2001;50:381-388.
12. Scammell TE, Nishino S, Mignot E, Saper CB: Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke. Neurology 2001;56:1751-1753.
13. Arii J, Kanbayashi T, Tanabe Y, et al: A hypersomnolent girl with decreased CSF hypocretin level after removal of a hypothalamic tumor. Neurology 2001;56:1775-1776.
14. Ripley B, Overeem S, Fujiki N, et al: CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 2001;57:2253-2258.